These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 29590200)
1. Retrospective harm benefit analysis of pre-clinical animal research for six treatment interventions. Pound P; Nicol CJ PLoS One; 2018; 13(3):e0193758. PubMed ID: 29590200 [TBL] [Abstract][Full Text] [Related]
2. The future of Cochrane Neonatal. Soll RF; Ovelman C; McGuire W Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834 [TBL] [Abstract][Full Text] [Related]
3. Screening for the primary prevention of fragility fractures among adults aged 40 years and older in primary care: systematic reviews of the effects and acceptability of screening and treatment, and the accuracy of risk prediction tools. Gates M; Pillay J; Nuspl M; Wingert A; Vandermeer B; Hartling L Syst Rev; 2023 Mar; 12(1):51. PubMed ID: 36945065 [TBL] [Abstract][Full Text] [Related]
4. Comparison of treatment effects between animal experiments and clinical trials: systematic review. Perel P; Roberts I; Sena E; Wheble P; Briscoe C; Sandercock P; Macleod M; Mignini LE; Jayaram P; Khan KS BMJ; 2007 Jan; 334(7586):197. PubMed ID: 17175568 [TBL] [Abstract][Full Text] [Related]
5. Harm-Benefit Analysis May Not Be the Best Approach to Ensure Minimal Harms and Maximal Benefits of Animal Research-Alternatives Should Be Explored. Gutfreund Y Animals (Basel); 2020 Feb; 10(2):. PubMed ID: 32059540 [TBL] [Abstract][Full Text] [Related]
6. Antenatal and intrapartum interventions for preventing cerebral palsy: an overview of Cochrane systematic reviews. Shepherd E; Salam RA; Middleton P; Makrides M; McIntyre S; Badawi N; Crowther CA Cochrane Database Syst Rev; 2017 Aug; 8(8):CD012077. PubMed ID: 28786098 [TBL] [Abstract][Full Text] [Related]
7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
8. Neonatal interventions for preventing cerebral palsy: an overview of Cochrane Systematic Reviews. Shepherd E; Salam RA; Middleton P; Han S; Makrides M; McIntyre S; Badawi N; Crowther CA Cochrane Database Syst Rev; 2018 Jun; 6(6):CD012409. PubMed ID: 29926474 [TBL] [Abstract][Full Text] [Related]
9. Harm-benefit analysis - what is the added value? A review of alternative strategies for weighing harms and benefits as part of the assessment of animal research. Grimm H; Olsson IAS; Sandøe P Lab Anim; 2019 Feb; 53(1):17-27. PubMed ID: 29966482 [TBL] [Abstract][Full Text] [Related]
10. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. McGoldrick E; Stewart F; Parker R; Dalziel SR Cochrane Database Syst Rev; 2020 Dec; 12(12):CD004454. PubMed ID: 33368142 [TBL] [Abstract][Full Text] [Related]
11. PCSK9 inhibitors and ezetimibe for the reduction of cardiovascular events: a clinical practice guideline with risk-stratified recommendations. Hao Q; Aertgeerts B; Guyatt G; Bekkering GE; Vandvik PO; Khan SU; Rodondi N; Jackson R; Reny JL; Al Ansary L; Van Driel M; Assendelft WJJ; Agoritsas T; Spencer F; Siemieniuk RAC; Lytvyn L; Heen AF; Zhao Q; Riaz IB; Ramaekers D; Okwen PM; Zhu Y; Dawson A; Ovidiu MC; Vanbrabant W; Li S; Delvaux N BMJ; 2022 May; 377():e069066. PubMed ID: 35508320 [TBL] [Abstract][Full Text] [Related]